Astral Cargill’s Cancer.vive Golf Classic Raises Funding For Cancer Causes
Seeking to deepen its commitment to cancer support, Astral Foods Limited (Astral), a leading Southern African integrated poultry producer, in partnership with Cargill in South Africa, launched the inaugural Cancer.vive Golf Classic in March this year, raising over R100,000 for cancer-related causes.
“We are delighted to have been able to extend our reach to Cancer.vive as part of our overall Corporate Social Investment (CSI) focus on cancer-related causes. We are pleased that our targets have been exceeded thanks to the generosity of our customers and suppliers,” said Chris Schutte, CEO of Astral Foods.
According to Paul Ruston, MD of Cargill, the company is proud to be a co-sponsor of the Cancer.vive Classic. “As a key supplier to Astral, this tournament provides an opportunity for us to partner on important and life-affirming causes such as this, and is a tangible way of showing our own support.”
As part of the fund-raising effort, prizes for the winners were awarded in the form of a cash donation to the cancer-related cause of the winners’ choice. “In this way we felt it would be something all participants could contribute to, and so be more meaningful for all involved,” stated Andy Crocker, Managing Director of Meadow Feeds, a subsidiary of Astral that organised the Classic. He added that Meadow Feeds’ donation of a specially-branded vehicle to Cancer.vive was part of this commitment. “This was generously augmented by Tom Terblanche, the CEO of Grain Carriers Group, who has committed to providing tyres for the vehicle for as long as it is used by Cancer.vive”.
One hundred and twenty players took part in the inaugural tournament, with various four-balls and individuals donating an additional R22,000 to Cancer.vive.
“Cancer.vive is honoured to have been selected as the partner for the Classic by Astral and Cargill. The tournament presents us with a unique opportunity to raise awareness of not only our organisation and its work, but also of the importance of early detection of the disease which affects so many South Africans from all walks of life,” said Janie du Plessis, CEO of Cancer.vive.